Browse by author
Lookup NU author(s): Rajeev ShresthaORCiD, Dr Emily Shaw, Dr David SinclairORCiD, Dr Felicity DewhurstORCiD, Professor Adam ToddORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© The Author(s) 2026. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Background: Polypharmacy and inappropriate medication are common amongst people with life-limiting conditions. Whilst deprescribing may help reduce these medication-related issues, supporting evidence in this population group is limited. Aim: To synthesise evidence on the outcomes of deprescribing in people with life-limiting conditions. Design: Systematic review. Data source: MEDLINE, Embase, Scopus, PsycINFO and CINAHL were searched. Original studies published between Jan 2000 and Dec 2024 in English were included. Result: A total of 17,457 hits were screened, of which 46 original studies met the inclusion criteria. Most eligible studies were pre-post interventional (n = 14) or cohort studies (n = 14), conducted primarily in nursing homes or long-term care facilities (n = 20) and hospitals (n = 16). The majority originated from North America (n = 20) and Australia (n = 7). A wide range of outcome variables were examined, with a primary focus on clinical outcomes. All studies assessing the impact on the number of medications used reported either a reduction in overall medication burden or inappropriate medications (n = 15), or no significant change (n = 3). Regarding mortality, most studies (10 studies) reported no impact, while 3 studies each reported increased and decreased mortality. For other outcomes, the majority of studies reported that deprescribing had no effect. Conclusion: This systematic review suggests that deprescribing offers some benefits, including reduced medication burden and costs in people with life-limiting conditions. While there is no strong evidence for harm, a small proportion of patients reported increased risks, so careful monitoring is essential. Further research should explore how deprescribing outcomes vary by disease condition and medication type.
Author(s): Shrestha R, Shaw E, Mullen L, Sinclair D, Dewhurst F, Todd A
Publication type: Review
Publication status: Published
Journal: Palliative Medicine
Year: 2026
Pages: epub ahead of print
Online publication date: 22/02/2026
Acceptance date: 02/04/2018
ISSN (print): 0269-2163
ISSN (electronic): 1477-030X
Publisher: SAGE Publications Ltd
URL: https://doi.org/10.1177/02692163261416281
DOI: 10.1177/02692163261416281
